Eight years after being named President of Thomas Jefferson University and CEO of Jefferson Health, Stephen K. Klasko, MD, MBA, will retire from his position, effective December 31, 2021.

Advocating for vulnerable populations to improve the care experience and health outcomes. 

CAR-T cells are less sensitive than other types of immunotherapy in detecting and killing melanoma cells, a finding that could help improve immunotherapy sensitivity. 

Plans national Consensus Conference on Research in Telehealth

Using sensory integration therapy tools can help patients and families live more successful and satisfying lives. 

History professor explores significance of conspiracy theories – and Senator Arlen Spector.

Therapies that target aging cells early pave the way to easing back pain.

Pancreatic disease – even when the diagnosis isn’t cancer – can have severe impacts on a person’s well-being, according to new research. 

Combatting misconceptions and investigating the benefits of cannabis in treating disease.